RespireRx Pharmaceuticals Inc.
DelistedCIK 849636fmd_1MSBRNFS0Y58GJEX8H65NA36BTManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2023, 54 periods
Latest annual · FY2022
Millions- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q3 FY2023
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2017 to FY2022
- n/m
RespireRx Pharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.6 million | -$2.6 million | 10-K 2023-04-17 · proof | |
| Net income | -$2.1 million | -$3.1 million | 10-K 2023-04-17 · proof | |
| Cash from operating activities | -$143,905 | -$956,172 | 10-K 2023-04-17 · proof | |
| Total assets | $22,781 | $208,737 | -89.1% | 10-K 2023-04-17 · proof |
| Total liabilities | $11.9 million | $10.2 million | +16.5% | 10-K 2023-04-17 · proof |
| Cash and cash equivalents | $88 | $1,398 | -93.7% | 10-K 2023-04-17 · proof |
- What was RespireRx Pharmaceuticals Inc.'s operating income in fiscal 2022?
- RespireRx Pharmaceuticals Inc. reported operating income of -$1.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2.6 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was RespireRx Pharmaceuticals Inc.'s net income in fiscal 2022?
- RespireRx Pharmaceuticals Inc. reported net income of -$2.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$3.1 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What was RespireRx Pharmaceuticals Inc.'s cash from operating activities in fiscal 2022?
- RespireRx Pharmaceuticals Inc. reported cash from operating activities of -$143,905 for fiscal 2022 (the year ended Dec 31, 2022), against -$956,172 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What are RespireRx Pharmaceuticals Inc.'s total assets?
- As of Dec 31, 2022, RespireRx Pharmaceuticals Inc. reported total assets of $22,781, against $208,737 a year earlier (-89.1%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What are RespireRx Pharmaceuticals Inc.'s total liabilities?
- As of Dec 31, 2022, RespireRx Pharmaceuticals Inc. reported total liabilities of $11.9 million, against $10.2 million a year earlier (+16.5%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
- What are RespireRx Pharmaceuticals Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, RespireRx Pharmaceuticals Inc. reported cash and cash equivalents of $88, against $1,398 a year earlier (-93.7%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:849636&period_type=annual&limit=5"Information only, not investment advice.